Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 470

1.

TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours.

Saito Y, Takahashi T, Obata Y, Nishida T, Ohkubo S, Nakagawa F, Serada S, Fujimoto M, Ohkawara T, Nishigaki T, Sugase T, Koh M, Ishida T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Nakajima K, Yamasaki M, Hirota S, Naka T, Mori M, Doki Y.

Br J Cancer. 2019 Dec 20. doi: 10.1038/s41416-019-0688-y. [Epub ahead of print]

PMID:
31857719
2.

Identification of serum microRNAs predicting the response of esophageal squamous-cell carcinoma to nivolumab.

Sudo K, Kato K, Matsuzaki J, Takizawa S, Aoki Y, Shoji H, Iwasa S, Honma Y, Takashima A, Sakamoto H, Naka T, Sekine S, Boku N, Ochiya T.

Jpn J Clin Oncol. 2019 Oct 15. pii: hyz146. doi: 10.1093/jjco/hyz146. [Epub ahead of print]

PMID:
31612917
3.

Organic Liquid Impregnation Behavior into Nanofibrous Membranes: Quantitative Analysis of the Effects of Structural Parameters.

Uematsu I, Naka T, Tokuno Y, Nakagawa Y, Matsumoto H.

ACS Omega. 2019 Sep 18;4(14):15856-15861. doi: 10.1021/acsomega.9b01738. eCollection 2019 Oct 1.

4.

Superconductivity under pressure in the Dirac semimetal PdTe2.

Leng H, Ohmura A, Anh LN, Ishikawa F, Naka T, Huang YK, de Visser A.

J Phys Condens Matter. 2019 Oct 1;32(2):025603. doi: 10.1088/1361-648X/ab49b5. [Epub ahead of print]

PMID:
31574487
5.

Loss of nivolumab binding to T cell PD-1 predicts relapse of Hodgkin lymphoma.

Ogasawara R, Hashimoto D, Sugita J, Yamawaki F, Naka T, Mitsuhashi T, Takahashi S, Miyashita N, Okada K, Onozawa M, Matsuno Y, Teshima T.

Int J Hematol. 2019 Sep 19. doi: 10.1007/s12185-019-02737-4. [Epub ahead of print]

PMID:
31538325
6.

Copper ions are novel therapeutic agents for uterine leiomyosarcoma.

Kakuda M, Matsuzaki S, Ueda Y, Shiomi M, Matsuzaki S, Kimura T, Fujita M, Egawa-Takata T, Kobayashi E, Serada S, Yoshino K, Naka T, Kimura T.

Am J Obstet Gynecol. 2020 Jan;222(1):64.e1-64.e16. doi: 10.1016/j.ajog.2019.07.030. Epub 2019 Jul 24.

PMID:
31351063
7.

Shape-Controlled Syntheses of Magnetite Microparticles and Their Magnetorheology.

Abe H, Naka T, Sato K, Suzuki Y, Nakano M.

Int J Mol Sci. 2019 Jul 24;20(15). pii: E3617. doi: 10.3390/ijms20153617.

8.

Erratum: Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis.

Shinzaki S, Matsuoka K, Iijima H, Mizuno S, Serada S, Fujimoto M, Arai N, Koyama N, Morii E, Watanabe M, Hibi T, Kanai T, Takehara T, Naka T.

J Crohns Colitis. 2019 Dec 10;13(12):1590. doi: 10.1093/ecco-jcc/jjz100. No abstract available.

9.

Primary tumor of the ureteral stump after a radical nephrectomy for renal cell carcinoma: case report and literature review.

Masago T, Naka T, Yoshida H, Takahashi C.

Int Cancer Conf J. 2019 Mar 20;8(3):126-129. doi: 10.1007/s13691-019-00369-3. eCollection 2019 Jul.

PMID:
31218189
10.

Myosin heavy chain, a novel allergen for fish allergy in patients with atopic dermatitis.

Shibata Y, Serada S, Fujimoto M, Oishi T, Ohko K, Fujieda M, Naka T, Sano S.

Br J Dermatol. 2019 Dec;181(6):1322-1324. doi: 10.1111/bjd.18226. Epub 2019 Aug 22. No abstract available.

PMID:
31209867
11.

Hepatocellular carcinoma producing granulocyte colony-stimulating factor: diagnosis and treatment.

Sakamoto Y, Kamiyama T, Yokoo H, Shimada S, Einama T, Wakayama K, Orimo T, Kamachi H, Naka T, Mitsuhashi T, Taketomi A.

Int Cancer Conf J. 2018 Sep 24;8(1):12-16. doi: 10.1007/s13691-018-0346-x. eCollection 2019 Jan.

12.

LRG is a novel inflammatory marker clinically useful for the evaluation of disease activity in rheumatoid arthritis and inflammatory bowel disease.

Naka T, Fujimoto M.

Immunol Med. 2018 Jun;41(2):62-67. doi: 10.1080/13497413.2018.1481582. Epub 2018 Sep 11.

PMID:
30938267
13.

Spodiobacter cordis gen. nov. sp. nov., a member of the family Flavobacteriaceae isolated from patients with infective endocarditis.

Tomida J, Fujiwara N, Naka T, Morita Y, Sawabe E, Tojo N, Kikuchi K, Kawamura Y.

Microbiol Immunol. 2019 Mar;63(3-4):111-118. doi: 10.1111/1348-0421.12673. Epub 2019 Apr 15.

PMID:
30817020
14.

Familial multifocal micronodular pneumocyte hyperplasia with a novel splicing mutation in TSC1: Three cases in one family.

Shoji T, Konno S, Niida Y, Ogi T, Suzuki M, Shimizu K, Hida Y, Kaga K, Seyama K, Naka T, Matsuno Y, Nishimura M.

PLoS One. 2019 Feb 22;14(2):e0212370. doi: 10.1371/journal.pone.0212370. eCollection 2019.

15.

Synthesis of the reported structure of homocereulide and its vacuolation assay.

Naka T, Hattori Y, Takenaka H, Ohta Y, Kirihata M, Tanimori S.

Bioorg Med Chem Lett. 2019 Mar 1;29(5):734-739. doi: 10.1016/j.bmcl.2019.01.007. Epub 2019 Jan 10.

PMID:
30665680
16.

Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guérin induce antitumor immunity in a syngeneic murine bladder cancer model.

Yoshino T, Miyazaki J, Kojima T, Kandori S, Shiga M, Kawahara T, Kimura T, Naka T, Kiyohara H, Watanabe M, Yamasaki S, Akaza H, Yano I, Nishiyama H.

PLoS One. 2019 Jan 4;14(1):e0209196. doi: 10.1371/journal.pone.0209196. eCollection 2019.

17.

Overexpression of SOCS3 mediated by adenovirus vector in mouse and human castration-resistant prostate cancer cells increases the sensitivity to NK cells in vitro and in vivo.

Yoneda T, Kunimura N, Kitagawa K, Fukui Y, Saito H, Narikiyo K, Ishiko M, Otsuki N, Nibu KI, Fujisawa M, Serada S, Naka T, Shirakawa T.

Cancer Gene Ther. 2019 Nov;26(11-12):388-399. doi: 10.1038/s41417-018-0075-5. Epub 2019 Jan 4.

PMID:
30607005
18.

Epithelial-mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine-rich alpha-2 glycoprotein.

Otsuru T, Kobayashi S, Wada H, Takahashi T, Gotoh K, Iwagami Y, Yamada D, Noda T, Asaoka T, Serada S, Fujimoto M, Eguchi H, Mori M, Doki Y, Naka T.

Cancer Sci. 2019 Mar;110(3):985-996. doi: 10.1111/cas.13918. Epub 2019 Feb 4.

19.

Small Cell Carcinomas of the Uterine Cervix and Lung: Proteomics Reveals Similar Protein Expression Profiles.

Egawa-Takata T, Yoshino K, Hiramatsu K, Nakagawa S, Serada S, Nakajima A, Endo H, Kubota S, Matsuzaki S, Kobayashi E, Ueda Y, Morii E, Inoue M, Naka T, Kimura T.

Int J Gynecol Cancer. 2018 Nov;28(9):1751-1757. doi: 10.1097/IGC.0000000000001354.

20.

Aphaenogaster gamagumayaa sp. nov.: the first troglobiotic ant from Japan (Hymenoptera: Formicidae: Myrmicinae).

Naka T, Maruyama M.

Zootaxa. 2018 Jul 23;4450(1):135-141. doi: 10.11646/zootaxa.4450.1.10.

PMID:
30313863
21.

Observation of the First Spin Crossover in an Iron(II) Complex with an S6 Coordination Environment: Tris[bis(N,N-diethylamino)carbeniumdithiocarboxylato]iron(II) Hexafluorophosphate.

Sugaya T, Fujihara T, Naka T, Furubayashi T, Matsushita A, Isago H, Nagasawa A.

Chemistry. 2018 Dec 5;24(68):17955-17963. doi: 10.1002/chem.201803330. Epub 2018 Nov 26.

PMID:
30311982
22.

Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer.

Sugase T, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Hiramatsu K, Koh M, Saito Y, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Hanazaki K, Mori M, Doki Y, Naka T.

Oncotarget. 2018 Aug 31;9(68):32917-32928. doi: 10.18632/oncotarget.25952. eCollection 2018 Aug 31.

23.

Hyponatremia and mortality among very elderly residents in a geriatric health service facility.

Naka T, Kohagura K, Kochi M, Ohya Y.

Clin Exp Nephrol. 2018 Dec;22(6):1404-1410. doi: 10.1007/s10157-018-1607-x. Epub 2018 Jun 27.

PMID:
29951722
24.

NQO1 inhibits the TLR-dependent production of selective cytokines by promoting IκB-ζ degradation.

Kimura A, Kitajima M, Nishida K, Serada S, Fujimoto M, Naka T, Fujii-Kuriyama Y, Sakamato S, Ito T, Handa H, Tanaka T, Yoshimura A, Suzuki H.

J Exp Med. 2018 Aug 6;215(8):2197-2209. doi: 10.1084/jem.20172024. Epub 2018 Jun 22.

25.

Intratumoral Delivery of an Adenoviral Vector Carrying the SOCS-1 Gene Enhances T-Cell-Mediated Antitumor Immunity By Suppressing PD-L1.

Nakagawa S, Serada S, Kakubari R, Hiramatsu K, Sugase T, Matsuzaki S, Matsuzaki S, Ueda Y, Yoshino K, Ohkawara T, Fujimoto M, Kishimoto T, Kimura T, Naka T.

Mol Cancer Ther. 2018 Sep;17(9):1941-1950. doi: 10.1158/1535-7163.MCT-17-0822. Epub 2018 Jun 11.

26.

Requirement of the 3'-UTR-dependent suppression of DAZL in oocytes for pre-implantation mouse development.

Fukuda K, Masuda A, Naka T, Suzuki A, Kato Y, Saga Y.

PLoS Genet. 2018 Jun 8;14(6):e1007436. doi: 10.1371/journal.pgen.1007436. eCollection 2018 Jun.

27.

Final Results of the OPERA Experiment on ν_{τ} Appearance in the CNGS Neutrino Beam.

Agafonova N, Alexandrov A, Anokhina A, Aoki S, Ariga A, Ariga T, Bertolin A, Bozza C, Brugnera R, Buonaura A, Buontempo S, Chernyavskiy M, Chukanov A, Consiglio L, D'Ambrosio N, De Lellis G, De Serio M, Del Amo Sanchez P, Di Crescenzo A, Di Ferdinando D, Di Marco N, Dmitrievsky S, Dracos M, Duchesneau D, Dusini S, Dzhatdoev T, Ebert J, Ereditato A, Favier J, Fini RA, Fornari F, Fukuda T, Galati G, Garfagnini A, Gentile V, Goldberg J, Gorbunov S, Gornushkin Y, Grella G, Guler AM, Gustavino C, Hagner C, Hara T, Hayakawa T, Hollnagel A, Ishiguro K, Iuliano A, Jakovcic K, Jollet C, Kamiscioglu C, Kamiscioglu M, Kim SH, Kitagawa N, Klicek B, Kodama K, Komatsu M, Kose U, Kreslo I, Laudisio F, Lauria A, Ljubicic A, Longhin A, Loverre P, Malenica M, Malgin A, Mandrioli G, Matsuo T, Matveev V, Mauri N, Medinaceli E, Meregaglia A, Mikado S, Miyanishi M, Mizutani F, Monacelli P, Montesi MC, Morishima K, Muciaccia MT, Naganawa N, Naka T, Nakamura M, Nakano T, Niwa K, Ogawa S, Okateva N, Olchevsky A, Ozaki K, Paoloni A, Paparella L, Park BD, Pasqualini L, Pastore A, Patrizii L, Pessard H, Pistillo C, Podgrudkov D, Polukhina N, Pozzato M, Pupilli F, Roda M, Roganova T, Rokujo H, Rosa G, Ryazhskaya O, Sadovsky A, Sato O, Schembri A, Shakiryanova I, Shchedrina T, Shibayama E, Shibuya H, Shiraishi T, Simone S, Sirignano C, Sirri G, Sotnikov A, Spinetti M, Stanco L, Starkov N, Stellacci SM, Stipcevic M, Strolin P, Takahashi S, Tenti M, Terranova F, Tioukov V, Tufanli S, Ustyuzhanin A, Vasina S, Vilain P, Voevodina E, Votano L, Vuilleumier JL, Wilquet G, Wonsak B, Yoon CS; OPERA Collaboration.

Phys Rev Lett. 2018 May 25;120(21):211801. doi: 10.1103/PhysRevLett.120.211801. Erratum in: Phys Rev Lett. 2018 Sep 28;121(13):139901.

PMID:
29883136
28.

SOCS1 gene therapy has antitumor effects in imatinib-resistant gastrointestinal stromal tumor cells through FAK/PI3 K signaling.

Sugase T, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Hiramatsu K, Nishida T, Hirota S, Saito Y, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Hanasaki K, Kishimoto T, Mori M, Doki Y, Naka T.

Gastric Cancer. 2018 Nov;21(6):968-976. doi: 10.1007/s10120-018-0822-1. Epub 2018 Apr 5.

PMID:
29623544
29.

Re-infection of Toxoplasma gondii after HSCT presenting lymphadenopathy resembling recurrence of lymphoma.

Hashiguchi J, Onozawa M, Naka T, Hatanaka KC, Shiratori S, Sugita J, Fujimoto K, Matsuno Y, Teshima T.

Transpl Infect Dis. 2018 Jun;20(3):e12892. doi: 10.1111/tid.12892. Epub 2018 Apr 19.

30.

Leucine rich α-2 glycoprotein is a potential urinary biomarker for renal tubular injury.

Lee H, Fujimoto M, Ohkawara T, Honda H, Serada S, Terada Y, Naka T.

Biochem Biophys Res Commun. 2018 Apr 15;498(4):1045-1051. doi: 10.1016/j.bbrc.2018.03.111. Epub 2018 Mar 17.

PMID:
29550485
31.

Spontaneous reduction of native kidney size involving angiomyolipoma lesions in a kidney transplant recipient with tuberous sclerosis complex.

Sasaki H, Iwami D, Hotta K, Morita K, Naka T, Shinohara N.

Int J Urol. 2018 May;25(5):513-514. doi: 10.1111/iju.13534. Epub 2018 Feb 8. No abstract available.

32.

Leucine-rich α-2 glycoprotein promotes lung fibrosis by modulating TGF-β signaling in fibroblasts.

Honda H, Fujimoto M, Serada S, Urushima H, Mishima T, Lee H, Ohkawara T, Kohno N, Hattori N, Yokoyama A, Naka T.

Physiol Rep. 2017 Dec;5(24). pii: e13556. doi: 10.14814/phy2.13556. Epub 2017 Dec 26.

33.

Characteristics of upper-limb pull power and power endurance in Japanese female wrestlers.

Naka T, Kanno M, Shidochi S, Sakae K, Shima N.

J Strength Cond Res. 2017 Nov 22. doi: 10.1519/JSC.0000000000002378. [Epub ahead of print]

PMID:
29210895
34.

LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake.

Hiramatsu K, Serada S, Enomoto T, Takahashi Y, Nakagawa S, Nojima S, Morimoto A, Matsuzaki S, Yokoyama T, Takahashi T, Fujimoto M, Takemori H, Ueda Y, Yoshino K, Morii E, Kimura T, Naka T.

Cancer Res. 2018 Jan 15;78(2):516-527. doi: 10.1158/0008-5472.CAN-17-0910. Epub 2017 Nov 29.

35.

Surgically Diagnosed Primary Hepatic Angiosarcoma.

Tsunematsu S, Muto S, Oi H, Naka T, Kitagataya T, Sasaki R, Taya Y, Baba U, Tsukamoto Y, Uemura K, Kimura T, Ohara Y.

Intern Med. 2018 Mar 1;57(5):687-691. doi: 10.2169/internalmedicine.9318-17. Epub 2017 Nov 20.

36.

Prevalence and associated factors of foot and ankle pain among nurses at a university hospital in Japan: A cross-sectional study.

Tojo M, Yamaguchi S, Amano N, Ito A, Futono M, Sato Y, Naka T, Kimura S, Sadamasu A, Akagi R, Ohtori S.

J Occup Health. 2018 Mar 27;60(2):132-139. doi: 10.1539/joh.17-0174-OA. Epub 2017 Nov 18.

37.

Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer.

Matsuzaki S, Serada S, Hiramatsu K, Nojima S, Matsuzaki S, Ueda Y, Ohkawara T, Mabuchi S, Fujimoto M, Morii E, Yoshino K, Kimura T, Naka T.

Int J Cancer. 2018 Mar 1;142(5):1056-1066. doi: 10.1002/ijc.31124. Epub 2017 Oct 31.

38.

SOCS1 Gene Therapy Improves Radiosensitivity and Enhances Irradiation-Induced DNA Damage in Esophageal Squamous Cell Carcinoma.

Sugase T, Takahashi T, Serada S, Fujimoto M, Hiramatsu K, Ohkawara T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Kishimoto T, Mori M, Doki Y, Naka T.

Cancer Res. 2017 Dec 15;77(24):6975-6986. doi: 10.1158/0008-5472.CAN-17-1525. Epub 2017 Oct 17.

39.

Evidence that glial cells attenuate G47R transthyretin accumulation in the central nervous system.

Sumi-Akamaru H, Eto M, Yamauchi A, Uehara T, Kakuda K, Obayashi K, Kato S, Naka T, Mochizuki H.

Neuropathology. 2018 Feb;38(1):11-21. doi: 10.1111/neup.12412. Epub 2017 Sep 28.

PMID:
28960480
40.

Case Report: Pulmonary Tumor Thrombotic Microangiopathy in a Cervical Cancer Patient.

Tsujimoto N, Miyoshi A, Mimura M, Naka T, Yamasaki M, Yokoi T.

Gynecol Obstet Invest. 2018;83(1):99-104. doi: 10.1159/000480400. Epub 2017 Sep 7.

PMID:
28877521
41.

Overexpression of leucine-rich α2-glycoprotein-1 is a prognostic marker and enhances tumor migration in gastric cancer.

Yamamoto M, Takahashi T, Serada S, Sugase T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Naka T, Mori M, Doki Y.

Cancer Sci. 2017 Oct;108(10):2052-2060. doi: 10.1111/cas.13329.

42.
43.

Transition-Metal-Free and Oxidant-Free Cross-Coupling of Arylhydrazines with Disulfides: Base-Promoted Synthesis of Unsymmetrical Aryl Sulfides.

Taniguchi T, Naka T, Imoto M, Takeda M, Nakai T, Mihara M, Mizuno T, Nomoto A, Ogawa A.

J Org Chem. 2017 Jul 7;82(13):6647-6655. doi: 10.1021/acs.joc.7b00767. Epub 2017 Jun 23.

PMID:
28616985
44.

Leucine-rich alpha 2 glycoprotein promotes Th17 differentiation and collagen-induced arthritis in mice through enhancement of TGF-β-Smad2 signaling in naïve helper T cells.

Urushima H, Fujimoto M, Mishima T, Ohkawara T, Honda H, Lee H, Kawahata H, Serada S, Naka T.

Arthritis Res Ther. 2017 Jun 14;19(1):137. doi: 10.1186/s13075-017-1349-2.

45.

Extra-Articular Tenosynovial Chondromatosis of the Finger: A Case Series Study of Three Cases, One Including Excessive Osseous Invasion.

Sakamoto A, Naka T, Shiba E, Hisaoka M, Matsuda S.

Open Orthop J. 2017 May 17;11:417-423. doi: 10.2174/1874325001711010417. eCollection 2017.

46.

Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinoma.

Harada E, Serada S, Fujimoto M, Takahashi Y, Takahashi T, Hara H, Nakatsuka R, Sugase T, Nishigaki T, Saito Y, Hiramatsu K, Nojima S, Mitsuo R, Ohkawara T, Morii E, Mori M, Doki Y, Kaneda Y, Naka T.

Oncotarget. 2017 Apr 11;8(15):24741-24752. doi: 10.18632/oncotarget.15799.

47.

A novel pathogenesis of inflammatory bowel disease from the perspective of glyco-immunology.

Shinzaki S, Iijima H, Fujii H, Kamada Y, Naka T, Takehara T, Miyoshi E.

J Biochem. 2017 May 1;161(5):409-415. doi: 10.1093/jb/mvx010.

PMID:
28338836
48.

Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.

Sugase T, Takahashi T, Serada S, Nakatsuka R, Fujimoto M, Ohkawara T, Hara H, Nishigaki T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Kishimoto T, Mori M, Doki Y, Naka T.

Int J Cancer. 2017 Jun 1;140(11):2608-2621. doi: 10.1002/ijc.30666. Epub 2017 Mar 10.

49.

Optimization of T1-weighted Imaging Parameters in MR Carotid Plaque Imaging: Influence for the Quantitative Evaluation among Different MRI Scanner Types.

Naka T, Takahashi M, Takeda K, Igarashi T, Hondera T.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2017;73(2):104-111. doi: 10.6009/jjrt.2017_JSRT_73.2.104. Japanese.

50.

Leucine-rich α-2 glycoprotein is an innovative biomarker for psoriasis.

Nakajima H, Serada S, Fujimoto M, Naka T, Sano S.

J Dermatol Sci. 2017 May;86(2):170-174. doi: 10.1016/j.jdermsci.2017.01.008. Epub 2017 Jan 29. No abstract available.

PMID:
28179066

Supplemental Content

Support Center